Sana Biotechnology Company
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Investors
Technology:
Cell therapy, Drug Delivery
Industry:
Cell Therapy, Public
Headquarters:
Seattle, Washington, United States
Founded Date:
2018-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
13
Total Funding:
700000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-06-23
Last Funding Type:
Series A
Register and Claim Ownership